10 results
Table of Weight-Loss Medications approved by the FDA for the long-term treatment of Obesity

Mechanism of Action,
Table of Weight-Loss ... approved by the FDA ... WeightLoss #AACE #2016 ... #Pharmacology #Table
Differential Diagnosis of Jaundice, Presentation Pattern #Diagnosis #EM #IM #GI #Jaundice #Pattern #LFTs #Workup #Table #Differential
Pattern #Diagnosis #EM ... #IM #GI #Jaundice ... #LFTs #Workup #Table
Simplified Algorithm for bradycardia with a pulse (Adapted from ACLS 2010) #Management #EM #IM #Prehosp #ACLS
Simplified Algorithm ... Adapted from ACLS 2010 ... ) #Management #EM ... #IM #Prehosp #ACLS ... #Bradycardia #Algorithm
Simplified Algorithm for tachycardia with a pulse (Adapted from ACLS 2010) #Management #EM #IM #Prehosp #ACLS
Simplified Algorithm ... Adapted from ACLS 2010 ... ) #Management #EM ... #IM #Prehosp #ACLS ... #Tachycardia #Algorithm
Jaundice Evaluation Algorithm #Diagnosis #Management #EM #IM #GI #Jaundice #Hyperbilirubinemia #Workup #Evaluation #Differential #Algorithm #Direct #Indirect
Jaundice Evaluation Algorithm ... Diagnosis #Management #EM ... #IM #GI #Jaundice ... #Differential #Algorithm
Algorithm for managing the failure of anti-TNF therapy. ADA=anti-drug antibody; IM=immunomodulator; MOA=mechanism of action; TNF=tumor necrosis
Algorithm for managing ... ADA=anti-drug antibody ... ; IM=immunomodulator ... factor #Management #GI ... #IM #IBD #AntiTNFFailure
Differential Diagnosis of Biliary Duct Dilation #Diagnosis #EM #IM #GI #Biliary #Bile #Duct #Dilatation #Differential #Algorithm
Dilation #Diagnosis #EM ... #IM #GI #Biliary ... #Differential #Algorithm
Intern Pocket Cards - Inpatient Anti-Emetics Guide
Serotonin antagonists:
 • Ondansetron (Zofran), Granisetron (Kytril, Sancuso) - Headache,
Dopamine antagonists (DA ... use if increased GI ... urinary retention DA ... #pharmacology #table
Alcohol Use Disorder - Maintenance Treatment
Naltrexone (first line) - First line for most people without contraindications
qday OR 380 mg IM ... TID Acamprosate (FDA ... TID Disulfiram (FDA ... #pharmacology #table
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... 2018. ... Administration (FDA ... since decitabine’s FDA ... #algorithm #hematology